Oligodendroglioma: A pathological and clinical study of 15 cases;Oligodendrogliomas: Estudo anatomopatológico e clínico de 15 casos

Arquivos de Neuro-Psiquiatria

Volumn 57, Issue 2 A, 1999, Pages 249-254

  Reis Filho, Jorge Sergio ^b   Montemór Netto, Mário Rodrigues ^c   Sluminsky, Beatriz Garcia ^c   Dellé, Linei Augusta Brolini ^c   Antoniuk, Afonso ^c   Ramina, Ricardo ^a   Bleggi Torres, Luiz Fernando ^c  

^a Medico Neurocirurgiao Hosp Nacoes   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c NONE

Author keywords

Central nervous system; Gliomas; Oligodendroglioma

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN TUMOR; BRAZIL; CENTRAL NERVOUS SYSTEM TUMOR; FEMALE; HUMAN; MALE; MIDDLE AGED; OLIGODENDROGLIOMA; PATHOLOGY; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; BRAIN NEOPLASMS; BRAZIL; CENTRAL NERVOUS SYSTEM NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OLIGODENDROGLIOMA;

EID: 0043237086     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x1999000200013     Document Type: Article

References (16)

1. Burger PC, Rawlings CE, Cox EB, McLendon RE, Schold SC Jr, Bullard DE. Clinicopathologic correlations in the oligodendroglioma. Cancer 1987;59:1345-1352
2. Chin HW, Hazel JJ, Kim TH, Webster JH. Oligodendroglioma: I. A clinical study of cerebral oligodendrogliomas. Cancer, 1980;45:1458-1466.
3. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol, 1993;3:255-268.
4. Bailey P, Cushing H. A classification of tumours of the glioma group on a histogenetic basis with a correlation study of prognosis. Lippincott:Philadelphia, 1926.
5. Ganju V, Jenkins RB, O'Fallon JR, et al., Prognostic factors in the gliomas: a multivariate analysis of clinical, pathologic, flow cytometric, cytogenetic, and molecular markers. Cancer. 1994;74:920-927.
6. Kros JM, Hop WC, Godschalk JJ, Krishnadath KK. Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas. Cancer, 1996;78:1107-1113.
7. Kros JM, Pieterman H, Van Eden CG, Avezaat CJ. Oligodendroglioma: The Rotterdan-Dijokzigt experience. Neurosurgery, 1994;34:959-966.
8. Mork SJ, Lindegaard KF, Halvorsen TB, et al. Oligodendroglioma: incidence and biological behaviour in a defined population. J Neurosurg, 1985;63:881-889.
9. Bancroft JD, Stevens A. Theory and practice of histological techniques. 2Ed. New York: Churchill Livingstone, 1982.
10. Packer RJ, Sutton LN, Rorke LB, et al., Oligodendroglioma of the posterior fossa in childhood. Cancer, 1985;56:195-199.
11. Kros JM, Godschalk JJ, Krishnadath KK, Van Eden CG. Expression of p53 in oligodendrogliomas. J Pathol, 1993;171:285-290.
12. Lee Y, Van Tassel P. Intracranial oligodendrogliomas: imaging findings in 35 untreated cases. Am J Roentgenol, 1989;152:361-369.
13. Shaw EG, Scheithauer BW, O'Fallon JR, Tazeelar HD, Davis DH. Oligodendroglioma: the Mayo Clinic experience. J Neurosurg, 1992;76:428-434.
14. Kros JM, de Jong A A, van der Kwast TH. Ultrastructural characterization of transitional cells in oligodendrogliomas. J Neuropathol Exp Neurol, 1992;51:186-193.
15. Kros JM, Van Eden CG, Stefanko SZ, Waayer Van Batenburg M, van der Kwast TH. Prognostic implications of glial fibrillary acidic protein containing cell types in oligodendrogliomas. Cancer, 1990;66:1204-1212.
16. Sung CC, Collins R, Li J, et al., Glycolipids and myelin proteins in human oligodendrogliomas. Glycoconj J, 1996;13:433-443.